The differing mechanisms of action of anti-obesity agents determines their varying impact on the cardiovascular system

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 24, Iss. 8, 2008-08 ,pp. : 19-21

Adis International

Access to resources Recommend Favorite

Obesity in the Cardiovascular Continuum

By  

Current Clinical Pharmacology, Vol. 8, Iss. 2, 2013-05 ,pp. : 159-163

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: Gender Differences in Cardiovascular Diseases. A Need for Action (Executive Guest Editors: Giuseppe Barbaro and Giuseppe M.C. Rosano)]

By  

Current Pharmaceutical Design, Vol. 17, Iss. 11, 2011-01 ,pp. : 1045-1045

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Treatment of Obesity in Cardiovascular Disease

By Charakida Marietta   Finer Nicholas  

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 2, 2012-04 ,pp. : 93-104

Adis International

Access to resources Recommend Favorite

Inflammation, Adiponectin, Obesity and Cardiovascular Risk

By  

Current Medicinal Chemistry, Vol. 17, Iss. 36, 2010-12 ,pp. : 4511-4520

Bentham Science Publishers

Access to resources Recommend Favorite